A tumor necrosis factor-α-inducible promoter variant of interferon-γ accelerates CD4+ t cell depletion in human immunodeficiency virus-1-infected individuals

Journal of Infectious Diseases

Volumn 188, Issue 2, 2003, Pages 228-231

  An, Ping ^a   Vlahov, David ^c   Margolick, Joseph B ^c   Phair, John ^e   O'Brien, Thomas R ^d   Lautenberger, James ^b   O'Brien, Stephen J ^b   Winkler, Cheryl A ^a,b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; NEGRO; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SEROCONVERSION;

ADULT; ALLELES; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041314090     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/376455     Document Type: Article

References (15)

1. O'Brien SJ, Nelson G.W, Winkler CA, Smith MW. Polygenic and multifactorial disease gene association in man: lessons from AIDS. Annu Rev Genet 2000; 34:563-91.
2. Poli G, Biswas P, Fauci AS. Interferons in the pathogenesis and treatment of human immunodeficiency virus infection. Antiviral Res 1994; 24:221-33.
3. Biswas P, Poli G, Orenstein JM, Fauci AS. Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected ceils? J Virol 1994; 68:2598-604.
4. Hart X, Becker K, Degen HJ, Jablonowski H, Strohmeyer G. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells. Eur J Clin Invest 1996; 26:286-92.
5. Bream JH, An P, Zhang X, Winkler CA, Young HA. A Single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription. Genes Immun 2002; 3:165-9.
6. Vlahov D, Graham N, Hoover D, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA 1998; 279:35-40.
7. Phair J, Jacobson L, Detels R, et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1992; 5:490-6.
8. Goedert JJ, Kessler CM, Aledort LM, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989; 321:1141-8.
9. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41:1-19.
10. Gao X, Nelson GW, Karacki P, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001; 344:1668-75.
11. Zaitseva M, Lee S, Lapham C, et al. Interferon gamma and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection. Blood 2000; 96:3109-17.
12. Barcellini W, Rizzardi GP, Poli G, et al. Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection. AIDS Res Hum Retroviruses 1996; 12:325-31.
13. Rizzardi GP, Marriott JB, Cookson S, Lazzarin A, Dalgleish AG, Barcellini W. Tumour necrosis factor (TNF) and TNF-related molecules in HIV-1+ individuals: relationship with in vitro Th1/Th2-type response. Clin Exp Immunol 1998; 114:61-5.
14. + T-cell number at the time of acquired immunodeficiency syndrome. Am J Epidemiol 1995; 141:645-51.
15. Shearer WT, Kline MW, Abramson SL, Fenton T, Starr SE, Douglas SD. Recombinant human gamma interferon in human immunodeficiency virus-infected children: safety, CD4(+)-lymphocyte count, viral load, and neutrophil function (AIDS Clinical Trials Group Protocol 211). Clin Diagn Lab Immunol 1999; 6:311-5.